A randomized, multicenter, controlled study, comparing efficacy and safety of a new complementary and alternative medicine (CAM) versus Solifenacin Succinate in women with overactive bladder syndrome
Submitted: September 25, 2017
Accepted: November 3, 2017
Published: December 31, 2017
Accepted: November 3, 2017
Abstract Views: 2326
PDF: 1327
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Vecchioli-Scaldazza, C., Morosetti, C., Maruccia, S., Casellato, S., Rociola, W., Illiano, E., & Garofalo, F. (2017). A randomized, multicenter, controlled study, comparing efficacy and safety of a new complementary and alternative medicine (CAM) versus Solifenacin Succinate in women with overactive bladder syndrome. Archivio Italiano Di Urologia E Andrologia, 89(4), 296–300. https://doi.org/10.4081/aiua.2017.4.296
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.